Sleep Apnea, Central: Clinical Trials

9 trials for Sleep Apnea, Central, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 recruiting, 2 unknown, 1 terminated. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Completed 4, Recruiting 2, Unknown 2, Terminated 1

Follow Sleep Apnea, Central: new trials by email Literature Review of Sleep Apnea, Central trials Research Report on Sleep Apnea, Central

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment
Trazodone + positive airway pressure (PAP) therapy, Oxygen + positive airway pressure (PAP) therapy - Sleep Disordered Breathing, Able Bodied
Phase 4RecruitingVA Office of Research and Development2002026-09-162026-10-13
Effects of Naltrexone on Nocturnal Breathing Patterns at Altitude
Naltrexone Pill, Placebo - Altitude, Sleep Apnea, Central
Phase 4CompletedVA Loma Linda Health Care System162021-08-082023-04-26
Central Sleep Apnea : Physiologic Mechanisms to Inform Treatment
Acetazolamide + supplemental oxygen + PAP therapy, Zolpidem + PAP therapy, Buspirone + PAP therapy - Sleep Disordered Breathing, Able Bodied
Phase 4RecruitingVA Office of Research and Development2002021-01-072026-07-20
Sleep and Breathing in the General Population - Chemical Stimuli
Zolpidem, No Treatment - Sleep-disordered Breathing
Phase 4CompletedWayne State University142018-07-032023-12-06
Nocturnal Oxygen Needs and Central Sleep Apnea in Patients With Chronic Heart Failure.
Titration of nocturnal oxygen needs to prevent desaturations - Chronic Heart Failure, Central Sleep Apnea
Phase 4UnknownLaval University142018-04-152022-04-08
Oxygen Versus Medical Air for Treatment of CSA in Prader Will Syndrome
Medical Air vs Oxygen - Sleep Apnea, Central, Prader-Willi Syndrome
Phase 4CompletedThe Hospital for Sick Children92016-09-012025-06-08
Benefit of One Month Zopiclone Intake on Adaptative Servoventilation Compliance
Zopiclone, Placebo - Sleep Apnea, Central, Ventricular Dysfunction
Phase 4TerminatedUniversity Hospital, Grenoble22016-05-012021-05-26
Effect of Acetazolamide on Central Sleep Apnea Related to Opium Consumption
Acetazolamide-placebo, Placebo-acetazolamide - Central Sleep Apnea, Secondary
Phase 4UnknownShahid Beheshti University of Medical Sciences122014-11-012018-05-08
Cardiac Resynchronisation Therapy in Combination With Overdrive Pacing in the Treatment of Central Sleep Apnea in CHF
CRT + AOP - Heart Failure, Central Sleep Apnea
Phase 4CompletedMedtronic Cardiac Rhythm and Heart Failure442005-06-012025-07-03

Narrower conditions

Sleep Apnea Syndromes (4)  ·  Heart Failure (3)  ·  Cheyne-Stokes Respiration (1)  ·  Creatine deficiency, X-linked (1)  ·  Opium Dependence (1)  ·  Prader-Willi Syndrome (1)  ·  Ventricular Dysfunction (1)

Broader conditions

Apnea (9)  ·  Dyssomnias (9)  ·  Nervous System Diseases (9)  ·  Respiration Disorders (9)  ·  Respiratory Tract Diseases (9)  ·  Sleep Disorders, Intrinsic (9)  ·  Sleep Wake Disorders (9)  ·  Sleep Apnea Syndromes (5)  ·  Cardiovascular Diseases (4)  ·  Heart Diseases (4)  ·  Abnormalities, Multiple (1)  ·  Chemically-Induced Disorders (1)  ·  Chromosome Disorders (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)

Interventions

Zolpidem (2)  ·  Acetazolamide (1)  ·  Buspirone (1)  ·  Naltrexone (1)  ·  Oxygen (1)  ·  Therapeutics (1)  ·  Trazodone (1)  ·  zopiclone (1)

Sponsors

VA Office of Research and Development (2)  ·  Laval University (1)  ·  Medtronic Cardiac Rhythm and Heart Failure (1)  ·  Shahid Beheshti University of Medical Sciences (1)  ·  The Hospital for Sick Children (1)  ·  University Hospital, Grenoble (1)  ·  VA Loma Linda Health Care System (1)  ·  Wayne State University (1)

Countries

United States (4)  ·  Canada (2)  ·  France (1)  ·  Germany (1)  ·  Iran (1)

Top investigators

M Safwan Badr, MD (2)  ·  James D Anholm, MD (1)  ·  M Safwan Badr, MD, MBA (1)  ·  Moein Forughi, MD (1)  ·  Parisa Adimi, MD (1)  ·  Reshma Amin, MD (1)  ·  S Andreas, Prof. Dr (1)

Results publications

PMID 31808012, PMID 35286569, PMID 38966963

NIH funding

I01CX001944 (1), I01RD001576 (1), R01HL130552 (1)